期刊文献+

某院短缺药品信息分析与应对策略探索 被引量:3

Analysis of Drug Shortage Characteristics and Countermeasures in a Hospital
下载PDF
导出
摘要 目的:分析某医院短缺药品的特征、发生原因、替代药品特征等,医院短缺药品供应保障制度的建立提供参考。方法:回顾性分析某院2016~2018年短缺药品信息,并参照美国药师协会短缺药品指南,对短缺药品的品规数、短缺原因、价格与剂型特征、是否为基本药物及替代药物特征进行分类汇总。结果:2016~2018年某院短缺药品的品规数为107种,其中基本药物42个品规,占比39.3%。原材料短缺是导致药品短缺的首要原因(占比37.4%),发生短缺的药品多数价格相对低廉(<50元药品占比73.9%),注射剂更易发生短缺(占比41.1%)。某院对短缺药品主要以不同厂家同规格药品替代(占比51.4%),替代药品价格通常较短缺药品高(占比63.4%)。结论:药品短缺给医疗机构等药品使用单位带来了许多治疗问题。搭建医疗机构内部短缺药品信息平台;确定短缺药品上报与发布专职人员;医生、护士及药学工作人员协同做好短缺药品院内限制使用管理和替代药物遴选,避免药品短缺发生时的人为差错都是应对医疗机构药品短缺的关键要素。 Objective:To analyze the characteristics and causes of drug shortage,the characteristics of alternative medicines and so on in a certain hospital,and combined with the actual situation of Chinese hospitals,explore the countermeasures for drug shortage in medical institutions,so as to provide reference for the establishment of drug shortage security system.Methods:Referring to the American Society of Health-System Pharmacists Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems,the drug shortage information from 2016 to 2018 was retrospectively analyzed in respects of the case number,shortage reasons,price,dosage forms,essential drugs and alternative drugs,etc.Results:Totally 107 drugs were in short supply during the past three years,including 42 essential drugs accounting for 39.3%.The shortage of raw materials was the leading cause of drug shortages(37.4%),and most of the shortage were relatively cheap(<50 yuan accounting for 73.9%),and injections were more prone to shortage(41.1%).The shortage drugs in the hospital were mainly replaced by the drugs with the same specification from different manufacturers(51.4%),and the price of alternative drug was usually higher than that of the drug in shortage(63.4%).Conclusion:Drug shortage poses a huge challenge to medical institutions.Setting up the information platform of drug shortage,determining the full-time personnel for reporting the shortage of drugs,doctors,nurses and pharmaceutical staff working together to manage the limited use of drugs and select alternative drugs,and avoiding human errors in drug shortages are the key factors to deal with drug shortages in hospitals and health systems.
作者 许秀丽 杨玉慧 张谦 张岩 李建涛 胡扬 左玮 刘鑫 杜小莉 梅丹 张波 Xu Xiuli;Yang Yuhui;Zhang Qian;Zhang Yan;Li Jiantao;Hu Yang;Zuo Wei;Liu Xin;Du Xiaoli;Mei Dan;Zhang Bo(Depart-ment of Pharmacy,Chinese Academy Medical Sciences&Peking Union Medical College Hospital,Beijing 100730,China)
出处 《中国药师》 CAS 2020年第2期326-329,共4页 China Pharmacist
关键词 药品短缺 应对策略 基本药物 替代药品 阳光采购 Drug shortage Coping strategies Essential drugs Alternative drugs Transparent drug purchases
  • 相关文献

参考文献5

二级参考文献38

  • 1胡彦.药品集中采购信息化管理模式的实施[J].中国药物经济学,2013,8(S3):173-175. 被引量:4
  • 2高晨,王孝蓉.美国医院药剂师协会药品缺货管理指南[J].中国医院药学杂志,2006,26(10):1289-1290. 被引量:11
  • 3U.S. Food and Drug Administration. A review ofFDA's approach to medical product shortages[EB/OL]. (2011- 10-31) [2012-10-23].http://www.fda.gov/downloads/Ab- outFDA/ReportsManualsForms/Reports/UCM277755.pdf.
  • 4Kevin Haninger, Amber Jessup, Kathleen Koehler. Eco- nomic analysis of the causes of drug shortages[EB/OL]. (2011-10) [2012-10-23].http://aspe.hhs.gov/sp/reports/ 2011/DrugShortages/ib.shtml.
  • 5国家食品药品监督管理局.北京市药品监督管理局紧急协调硫酸鱼精蛋白注射液生产保障临床救治需求[EB/OL].(2011-09-15)[2012-10-23].http:Ilwww.sda.gov.cn/WSOI/CL0005/65421.html.
  • 6American Society of Health-System Pharmacists. ASHP guidelines on managing drug product shortages in hospi- tals and health systems[EB/OL]. (2009-01-15) [2012- 12-05].http://www.ashp.org/DocLibrary/BestPractices/Pr- ocureGdlShortages.aspx.
  • 7Jensen V, Kimzey LM, Goldberger MJ. FDA' s role in re- sponding to drug shortages[J]. Am J Health Syst Pharm, 2002,59(15):1 423.
  • 8中国药学会药事管理专业委员会.关于做好传染病治疗药品和急救药品类基本药物供应保障工作的意见[C]∥中国医药卫生改革与发展相关文件汇编:2011-2012年度.北京:中国医药科技出版社,2012:294-297.
  • 9Margaret Hamburg. Six month check-up: FDA' s work on drug shortages[EB/OL]. (2012-05-03) [2012-10-23].ht- tp ://blogs.fda.gov/fdavoice/index.php/2012/05/six-month- check-up-fdas-work-on-drug-shortages/.
  • 10卫生部.关于开展用量小临床必需的基本药物品种定点生产试点的通[EB/OL].(2012-11-27)[2012-12-05].http:Ilwww.moh.gov.cn/publicfiles/business/htmlfiles/mo-hywzc/s3581/201211/56337.htm.

共引文献32

同被引文献37

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部